Epidemiology, Biostatistics and Study Design (EBSD) Core
流行病学、生物统计学和研究设计 (EBSD) 核心
基本信息
- 批准号:10215389
- 负责人:
- 金额:$ 14.54万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-07-01 至 2024-06-30
- 项目状态:已结题
- 来源:
- 关键词:AchievementAddressArchivesBiologicalBiologyBiometryBiostatistical MethodsBiostatistics CoreBone DensityBone DiseasesCharacteristicsClinicalClinical InvestigatorClinical ResearchClinical SciencesClinical TrialsCohort StudiesCollaborationsCommunitiesCommunity MedicineConsultConsultationsCustomDNAData AnalysesDatabasesDegenerative polyarthritisDiagnosisEducational CurriculumEnrollmentEnsureEpidemiologistEpidemiologyFractureFundingGuidelinesHealthHip OsteoarthritisImageIndividualInstitutesKnee OsteoarthritisKnowledgeLearning ModuleMedicineMusculoskeletalNational Institute of Arthritis and Musculoskeletal and Skin DiseasesNatural HistoryObservational StudyOsteoporosisPaperPathogenesisPersonsProductivityProtocols documentationReproducibilityResearchResearch DesignResearch PersonnelResourcesRisk FactorsRunningScientistSerumServicesSourceTechniquesTestingTrainingTranslational ResearchUnited States National Institutes of HealthWhole BloodWomanWorkanalytical methodarthropathiesbench to bedsideclinical databaseclinical developmentcohortcontinuing medical educationdata managementdata resourcedesignexperiencefollow-upinnovationinvestigator traininglongitudinal databasemembermennovelosteoporosis with pathological fracturepatient orientedprogramsracial diversityradiological imagingrandomized trialsuccesstooltranslational scientist
项目摘要
The Epidemiology, Biostatistics and Study Design (EBSD) Core will enhance productivity in
musculoskeletal research by providing unique epidemiologic resources that encourage collaborations between
basic, translational, and clinical researchers, and by supporting researchers with crucial consultative services
and educational tools to ensure the rigor and reproducibility of their work. The EBSD Core thus reaches across
the bench-to-bedside continuum and is designed to serve all Core Center for Musculoskeletal Biology and
Medicine (CCMBM) members.
The proposed EBSD Core will build on the achievements of the current CCMBM Epidemiology and
Biostatistics Core, maintaining successful programs and adding new, innovative initiatives. One key aim of the
EBSD Core is to provide access to and facilitate use of large osteoporosis and osteoarthritis (OA) longitudinal
databases from observational studies and clinical trials coordinated by UCSF, including rich associated
biological and imaging resources (Aim 1). These studies and trials have been funded by NIAMS, other NIH
institutes, and non-NIH entities. By facilitating use of these unique clinical study resources, the EBSD Core will
enable CCMBM members to test hypotheses and techniques regarding the pathogenesis, natural history, risk
factors, and diagnosis of bone and joint diseases. Another EBSD Core objective is to provide individualized
consultative services to the CCMBM community (Aim 2). The Core will increase access to and use of study
design, biostatistical, data management, and related consultations, using Core resources and leveraging
UCSF Clinical and Translational Science Institute (CTSI) consulting services (Aim 2a). As it does this, the Core
will also strengthen patient-oriented clinical research in musculoskeletal health at UCSF by creating an
innovative “study implementation coaching” service, targeting junior investigators and others new to the field
(Aim 2b). To expand the Core’s reach even further, the Core Director and Co-Directors will enhance
musculoskeletal research opportunities within clinical departments and research groups by building
collaborations and embedding epidemiologists within those groups (Aim 2c). Finally, the EBSD Core will
educate the CCMBM community (Aim 3), training investigators in good study design and execution practices
and in analytic methods, to maximize the rigor and validity of their work. This will involve the creation of novel,
customized educational modules specifically tailored to musculoskeletal investigators, including basic and
translational investigators (Aim 3a). The Core will also increase access to and use of formal coursework by
CCMBM members by leveraging the UCSF Training in Clinical Research and Osteoporosis Continuing Medical
Education programs. In accomplishing these aims, the EBSD Core will serve CCMBM members across the
bench-to-bedside continuum, enhancing productivity and stimulating collaborations in the musculoskeletal
research community.
流行病学,生物统计学和研究设计(EBSD)核心将提高生产力,
肌肉骨骼研究,提供独特的流行病学资源,鼓励
基础、转化和临床研究人员,并通过为研究人员提供重要的咨询服务
和教育工具,以确保其工作的严谨性和可重复性。因此,EBSD核心跨越了
从工作台到床边的连续统一体,旨在为所有肌肉骨骼生物学核心中心提供服务,
医学(CCMBM)成员。
拟议的EBSD核心将建立在当前CCMBM流行病学的成就基础上,
生物统计学核心,保持成功的计划和增加新的,创新的举措。一个关键的目标,
EBSD核心是提供访问和促进使用大型骨质疏松症和骨关节炎(OA)纵向
来自UCSF协调的观察性研究和临床试验的数据库,包括丰富的
生物和成像资源(目标1)。这些研究和试验由NIAMS,其他NIH
研究所和非NIH实体。通过促进这些独特的临床研究资源的使用,EBSD核心将
使CCMBM成员能够测试有关发病机制,自然史,风险
影响因素及骨关节疾病的诊断。EBSD的另一个核心目标是提供个性化的
为CCMBM社区提供咨询服务(目标2)。核心将增加获得和使用研究
设计、生物统计、数据管理和相关咨询,利用核心资源和杠杆作用
UCSF临床和转化科学研究所(CTSI)咨询服务(目标2a)。当它这样做时,核心
还将加强以病人为导向的临床研究,在肌肉骨骼健康在加州大学旧金山分校创建一个
创新的“研究实施辅导”服务,针对初级研究人员和其他新进入该领域的人员
(Aim 2b)。为了进一步扩大核心的影响力,核心主任和联席主任将加强
在临床科室和研究小组内进行肌肉骨骼研究的机会,
在这些群体中嵌入流行病学家(目标2c)。最后,EBSD核心将
教育CCMBM社区(目标3),培训研究者良好的研究设计和执行实践
在分析方法方面,最大限度地提高他们工作的严谨性和有效性。这将涉及到小说的创作,
专门为肌肉骨骼研究者量身定制的教育模块,包括基础和
翻译研究者(目标3a)。核心课程还将通过以下方式增加获得和使用正式课程的机会:
CCMBM成员通过利用UCSF临床研究和骨质疏松持续医学培训
教育项目。在实现这些目标的过程中,EBSD核心将为CCMBM成员提供服务。
从工作台到床边的连续性,提高生产力并促进肌肉骨骼领域的合作
研究社区。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Dennis M Black其他文献
Predictors of response in PROMIS-global in a chronic low back pain specialty clinic: STarTBack and chronic overlapping pain conditions.
慢性腰痛专科诊所中 PROMIS-global 反应的预测因素:STarTBack 和慢性重叠疼痛状况。
- DOI:
10.3233/bmr-230067 - 发表时间:
2024 - 期刊:
- 影响因子:1.6
- 作者:
Patricia Zheng;Susan Ewing;Angelina Tang;Dennis M Black;Trisha Hue;Jeffrey Lotz;Thomas Peterson;Abel Torres;Conor O’Neill - 通讯作者:
Conor O’Neill
Bone mineral density as a surrogate endpoint for fracture risk reduction in clinical trials of osteoporosis therapies: an update on SABRE
骨矿物质密度作为骨质疏松症治疗临床试验中骨折风险降低的替代终点:SABRE 的最新情况
- DOI:
10.1016/s2213-8587(24)00092-5 - 发表时间:
2024-06-01 - 期刊:
- 影响因子:41.800
- 作者:
Dennis M Black;Austin R Thompson;Richard Eastell;Mary L Bouxsein - 通讯作者:
Mary L Bouxsein
Dennis M Black的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Dennis M Black', 18)}}的其他基金
DDTBMQ000054: Regulatory qualification for DXA bone mineral density as a surrogate endpoint for fracture risk in osteoporosis trials
DDTBMQ000054:DXA 骨矿物质密度作为骨质疏松症试验中骨折风险替代终点的监管资格
- 批准号:
10623740 - 财政年份:2022
- 资助金额:
$ 14.54万 - 项目类别:
Beta1-selective blockade for prevention of postmenopausal bone loss: A randomized controlled trial
选择性阻断 Beta1 预防绝经后骨质流失:一项随机对照试验
- 批准号:
10133380 - 财政年份:2021
- 资助金额:
$ 14.54万 - 项目类别:
Beta1-selective blockade for prevention of postmenopausal bone loss: A randomized controlled trial
选择性阻断 Beta1 预防绝经后骨质流失:一项随机对照试验
- 批准号:
10321957 - 财政年份:2021
- 资助金额:
$ 14.54万 - 项目类别:
Beta1-selective blockade for prevention of postmenopausal bone loss: A randomized controlled trial
选择性阻断 Beta1 预防绝经后骨质流失:一项随机对照试验
- 批准号:
10553595 - 财政年份:2021
- 资助金额:
$ 14.54万 - 项目类别:
Epidemiology, Biostatistics and Study Design (EBSD) Core
流行病学、生物统计学和研究设计 (EBSD) 核心
- 批准号:
10460470 - 财政年份:2019
- 资助金额:
$ 14.54万 - 项目类别:
Epidemiology, Biostatistics and Study Design (EBSD) Core
流行病学、生物统计学和研究设计 (EBSD) 核心
- 批准号:
10642790 - 财政年份:2019
- 资助金额:
$ 14.54万 - 项目类别:
Trial Of Late SURFactant (TOLSURF) to Prevent BPD-Data Coordinating Center
试验晚期 SURFactant (TOLSURF) 预防 BPD-数据协调中心
- 批准号:
8119625 - 财政年份:2009
- 资助金额:
$ 14.54万 - 项目类别:
Trial Of Late SURFactant (TOLSURF) to Prevent BPD-Data Coordinating Center
试验晚期 SURFactant (TOLSURF) 预防 BPD-数据协调中心
- 批准号:
7564148 - 财政年份:2009
- 资助金额:
$ 14.54万 - 项目类别:
Trial Of Late SURFactant (TOLSURF) to Prevent BPD-Data Coordinating Center
试验晚期 SURFactant (TOLSURF) 预防 BPD-数据协调中心
- 批准号:
8518442 - 财政年份:2009
- 资助金额:
$ 14.54万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 14.54万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 14.54万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 14.54万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 14.54万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 14.54万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 14.54万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 14.54万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 14.54万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 14.54万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 14.54万 - 项目类别:
Research Grant